Aratana Therapeutics Reports First Quarter 2016 Financial Results
Go back to Aratana Therapeutics Reports First Quarter 2016 Financial Results| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1123.00 -1.21 (0.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1124.21 | 52 Week High | $88.16 | |||
| Open | $1126.08 | 52 Week Low | $67.88 | |||
| Day High | $1133.79 | P/E | 259.95 | |||
| Day Low | $1120.52 | EPS | $4.32 | |||
| Volume | 1,944,058 | |||||
| ARATANA THERAPEUTIC (NASDAQ: PETX) | Delayed: 4.92 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.92 | 52 Week High | $10.73 | |||
| Open | $11.31 | 52 Week Low | $2.56 | |||
| Day High | $4.92 | P/E | N/A | |||
| Day Low | $4.92 | EPS | $-1.01 | |||
| Volume | 899 | |||||

